Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925
Evanston, Ill., July 13, 2016 - Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate (NMDA) receptor for the... Read more
Profound Medical Corp. and Philips Sign Sales and Marketing Agreement in MRI-guided therapy for prostate cancer
TORONTO and AMSTERDAM, Netherlands, May 11, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSXV:PRN), a Toronto-based medical device company and... Read more